Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    In-vitro models & assays to identify novel therapies for neuroinflammatory diseases

    Forecasted

    In-vitro models & assays to identify novel therapies for neuroinflammatory diseases supports researchers developing human-centered models and assays to discover and optimize small-molecule treatments.

    OverviewSimilar Grants
    OverviewSimilar Grants

    Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)

    This grant supports creating and validating animal models and tissue systems mimicking neurological disorders to advance neurotherapeutic discovery.

    HHS-NIH11Due Oct 20, 2026· 2d$750,000

    Artificial intelligence in cell culture media and process development

    Artificial intelligence in cell culture media and process development supports researchers building adaptable models to optimize media feeds across mammalian hosts, improving bioprocess efficiency and conserving resources.

    EMD Group (Merck KGaA)Forecasted Aug 31, 2027$450,000Forecasted

    Targets to Therapies: Mitochondrial Target Validation

    Targets to Therapies: Mitochondrial Target Validation supports researchers studying mitochondrial targets to build evidence that guides therapeutic decisions for Parkinson’s disease.

    Fox FoundationRolling submissions

    Functional Target Validation for Alzheimer's Disease-Related Dementias

    This grant supports research to rigorously validate new therapeutic targets for Alzheimer's Disease-Related Dementias, aiming to accelerate treatment development through phased, milestone-driven projects.

    HHS-NIH11Forecasted Nov 6, 2026· 19d$1,800,000Forecasted

    Translational Centers Using Microphysiologic Systems for Infectious Diseases

    This grant supports developing human microphysiologic systems to study infectious diseases and advance drug or biologic product development, aiming to reduce animal testing and improve regulatory acceptance.

    HHS-NIH11Forecasted Jan 29, 2027$7,000,000Forecasted